Qualigen to present at the oppenheimer fall healthcare life sciences & medtech summit

Carlsbad, calif., sept. 15, 2021 (globe newswire) -- qualigen therapeutics, inc. (nasdaq: qlgn), a biotechnology company focused on developing treatments for adult and pediatric cancers with potential for orphan drug designation, announced today that ceo and chairman michael poirier will present at the oppenheimer fall healthcare life sciences & medtech summit september 20-23, 2021.
QLGN Ratings Summary
QLGN Quant Ranking